ROBERT BAFFI - 20 Feb 2026 Form 4 Insider Report for Neurogene Inc. (NGNE)

Role
Director
Signature
/s/ Donna M. Cochener as attorney-in-fact for Robert Baffi
Issuer symbol
NGNE
Transactions as of
20 Feb 2026
Net transactions value
$0
Form type
4
Filing time
24 Feb 2026, 18:41:39 UTC
Previous filing
13 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
BAFFI ROBERT Director C/O NEUROGENE INC., 535 W 24TH STREET, 5TH FLOOR, NEW YORK /s/ Donna M. Cochener as attorney-in-fact for Robert Baffi 24 Feb 2026 0001274826

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NGNE Non-Qualified Stock Option (right to buy) Award $0 +12,050 $0.000000 12,050 20 Feb 2026 Common Stock 12,050 $17.64 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 1/12 of the total shares monthly beginning March 20, 2026 until the option is fully vested on February 20, 2027, subject to the Reporting Person's provision of service to the Issuer on each vesting date.